Table 1.
Comparative study of the percentage of viability among Caco-2, SW-480 and HT-29 cell lines at different time of treatments.
Time | Treatment | Caco-2 | SW-480 | HT-29 | P value |
---|---|---|---|---|---|
24 H | NT | 0.72 ± 0.07 | 1.30 ± 0.23 | 0.80 ± 0.17 | 0.012 |
OXA | 0.51 0.09 | 1.22 ± 0.11 | 0.58 ± 0.05 | < 0.001 | |
CETU | 0.67 ± 0.12 | 1.27 ± 0.20 | 0.59 ± 0.16 | 0.004 | |
OXA+ CETU | 0.29 ± 0.05 | 1.03 ± 0.28 | 0.57 ± 0.10 | 0.006 | |
48 H | NT | 1.29 ± 0.24 | 2.36 ± 0.13 | 1.22 ± 0.07 | <0.001 |
OXA | 0.73 ± 0.15 | 1.31 ± 0.22 | 1.08 ± 0.05 | 0.012 | |
CETU | 1.03 ± 0.11 | 1.88 ± 0.15 | 1.28 ± 0.41 | 0.017 | |
OXA+ CETU | 0.91 ± 0.06 | 1.32 ± 0.13 | 1.05 ± 0.20 | 0.032 | |
72 H | NT | 3.48 ± 0.02 | 3.23 ± 0.40 | 2.02 ± 0.11 | 0.017 |
OXA | 1.44 ± 0.13 | 1.19 ± 0.25 | 0.89 ± 0.07 | 0.100 | |
CETU | 3.03 ± 0.15 | 3.13 ± 0.11 | 2.43 ± 0.31 | 0.079 | |
OXA+ CETU | 1.55 ± 0.15 | 1.26 ± 0.03 | 1.00 ± 0.08 | 0.025 |